English

Kitov Pharma Ltd.

EDGAR

KTOV Report (type unavailable) · filed 2026-10-05

382 filing records in this dataset, filed from 2015-09-24 to 2026-10-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

1 million USD

2020 · USD

Exact inputs and evidence

Revenue: 1000000 USD Source

Operating margin

-1,261.2%

2020 · %

Exact inputs and evidence

Operating Income: -12612000 USD Source
Revenue: 1000000 USD Source

Operating cash flow

1.71 million USD

2020 · USD

Exact inputs and evidence

Operating Cash Flow: 1705000 USD Source

Free cash flow

1.55 million USD

2020 · USD

Exact inputs and evidence

Operating Cash Flow: 1705000 USD Source
Capital Expenditure: 156000 USD Source

Cash and cash equivalents: 8.72 million USD 2025-12-31 Source
Exact value

8717000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-05.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2020-12-31
Operating income: 9 of 11 periods available· newest 2023-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 10 of 11 periods available· newest 2025-12-31
Total assets: 10 of 11 periods available· newest 2025-12-31
liabilities: No compatible figures in this window
Current assets: 10 of 11 periods available· newest 2025-12-31
Current liabilities: 10 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 19.15 million

Prior period

−USD 7.24 million

2024-01-01 – 2024-12-31
Current period

−USD 26.39 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-26386000 − -7240000 = -19146000 USD

-7240000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-26386000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Year-over-year change in Net income: -19146000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -26386000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1568818 Filing: 000121390026031365 Input fundies:NetIncome: -7240000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1569205 Filing: 000121390026031365
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 8.71 million

Prior period

−USD 14.37 million

2024-01-01 – 2024-12-31
Current period

−USD 5.66 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-5656000 − -14367000 = 8711000 USD

-14367000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-5656000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Year-over-year change in Operating cash flow: 8711000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -5656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1716768 Filing: 000121390026031365 Input fundies:OperatingCashFlow: -14367000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1717187 Filing: 000121390026031365
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2020 2020-01-01 – 2020-12-31

Revenue USD 1 million 100% of revenue
Operating costs Derived USD 13.61 million 1,361% of revenue
Operating income −USD 12.61 million −1,261% of revenue
Tax, interest and other Derived −USD 40.61 million −4,061% of revenue
Net income USD 28 million 2,800% of revenue

Cash

Operating cash flow USD 1.71 million 171% of revenue
Capital expenditure USD 156,000 16% of revenue
Free cash flow Derived USD 1.55 million 155% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2017 Operating loss: operating costs were 12,066% of revenue.
2018 Operating loss: operating costs were 883% of revenue.
2019 Operating loss: operating costs were 816% of revenue.
2020 Operating loss: operating costs were 1,361% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2017 2017-01-01 – 2017-12-31	100000	12066000 Derived	-11966000	-24143000 Derived	12177000	-8640000 Derived	Source 2017-01-01 – 2017-12-31: 100000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -11966000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: 12177000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -8627000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 13000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	1000000	8826000 Derived	-7826000	-13026000 Derived	5200000	-8496000 Derived	Source 2018-01-01 – 2018-12-31: 1000000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -7826000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 5200000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -8480000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 16000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	1000000	8156000 Derived	-7156000	-13006000 Derived	5850000	-1979000 Derived	Source 2019-01-01 – 2019-12-31: 1000000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -7156000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 5850000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -1968000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 11000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	1000000	13612000 Derived	-12612000	-40611000 Derived	27999000	1549000 Derived	Source 2020-01-01 – 2020-12-31: 1000000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -12612000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 27999000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 1705000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 156000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1M 2020

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Revenue	100000	Revenue: 100000 Open source
20182018-12-31	Revenue	1000000	Revenue: 1000000 Open source
20192019-12-31	Revenue	1000000	Revenue: 1000000 Open source
20202020-12-31	Revenue	1000000	Revenue: 1000000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

0% 2020

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Year over year	No prior comparable period	Revenue: 100000 Open source
20182018-12-31	Year over year	900%	Revenue: 1000000 Open source Revenue: 100000 Open source
20192019-12-31	Year over year	0%	Revenue: 1000000 Open source Revenue: 1000000 Open source
20202020-12-31	Year over year	0%	Revenue: 1000000 Open source Revenue: 1000000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,261.2% 2020

Net margin 2,799.9% 2020

Free cash flow margin 154.9% 2020

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Operating margin	-11,966%	Operating Income: -11966000 Open source Revenue: 100000 Open source
20182018-12-31	Operating margin	-782.6%	Operating Income: -7826000 Open source Revenue: 1000000 Open source
20192019-12-31	Operating margin	-715.6%	Operating Income: -7156000 Open source Revenue: 1000000 Open source
20202020-12-31	Operating margin	-1,261.2%	Operating Income: -12612000 Open source Revenue: 1000000 Open source
20172017-12-31	Net margin	12,177%	Net Income: 12177000 Open source Revenue: 100000 Open source
20182018-12-31	Net margin	520%	Net Income: 5200000 Open source Revenue: 1000000 Open source
20192019-12-31	Net margin	585%	Net Income: 5850000 Open source Revenue: 1000000 Open source
20202020-12-31	Net margin	2,799.9%	Net Income: 27999000 Open source Revenue: 1000000 Open source
20172017-12-31	Free cash flow margin	-8,640%	Revenue: 100000 Open source Operating Cash Flow: -8627000 Open source Capital Expenditure: 13000 Open source
20182018-12-31	Free cash flow margin	-849.6%	Revenue: 1000000 Open source Operating Cash Flow: -8480000 Open source Capital Expenditure: 16000 Open source
20192019-12-31	Free cash flow margin	-197.9%	Revenue: 1000000 Open source Operating Cash Flow: -1968000 Open source Capital Expenditure: 11000 Open source
20202020-12-31	Free cash flow margin	154.9%	Revenue: 1000000 Open source Operating Cash Flow: 1705000 Open source Capital Expenditure: 156000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.7M 2020

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Operating cash flow	-8627000	Operating Cash Flow: -8627000 Open source
20182018-12-31	Operating cash flow	-8480000	Operating Cash Flow: -8480000 Open source
20192019-12-31	Operating cash flow	-1968000	Operating Cash Flow: -1968000 Open source
20202020-12-31	Operating cash flow	1705000	Operating Cash Flow: 1705000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 1.5M 2020

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20172017-12-31	Free cash flow	-8640000	Operating Cash Flow: -8627000 Open source Capital Expenditure: 13000 Open source
20182018-12-31	Free cash flow	-8496000	Operating Cash Flow: -8480000 Open source Capital Expenditure: 16000 Open source
20192019-12-31	Free cash flow	-1979000	Operating Cash Flow: -1968000 Open source Capital Expenditure: 11000 Open source
20202020-12-31	Free cash flow	1549000	Operating Cash Flow: 1705000 Open source Capital Expenditure: 156000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2017-12-31	Liabilities / assets	Not reported	Total Assets: 14183000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 14723000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 14718000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 83803000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

19.14× 2020

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20172017-12-31	Current assets / current liabilities	2.01×	Current Assets: 7983000 Open source Current Liabilities: 3973000 Open source
20182018-12-31	Current assets / current liabilities	2.57×	Current Assets: 8514000 Open source Current Liabilities: 3314000 Open source
20192019-12-31	Current assets / current liabilities	2.34×	Current Assets: 8302000 Open source Current Liabilities: 3546000 Open source
20202020-12-31	Current assets / current liabilities	19.14×	Current Assets: 59282000 Open source Current Liabilities: 3098000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	USD 12.13 million Exact value Exact value: 12125000 USD 2016-01-01 – 2016-12-31: 12125000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2016-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 12125000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12125000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390019004878/ktov-20181231.xml#192515 Filing: 000121390019004878 The citation records this snapshot. The page link may show a newer release later.	−USD 6.26 million Exact value Exact value: -6262000 USD 2016-01-01 – 2016-12-31: -6262000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2016-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -6262000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6262000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390019004878/ktov-20181231.xml#244144 Filing: 000121390019004878 The citation records this snapshot. The page link may show a newer release later.	USD 10,000 Exact value Exact value: 10000 USD 2016-01-01 – 2016-12-31: 10000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2016-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 10000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390019004878/ktov-20181231.xml#246841 Filing: 000121390019004878 The citation records this snapshot. The page link may show a newer release later.	−USD 6.27 million Calculation and evidence -6262000 − 10000 USD Exact free cash flow: -6272000 USD 2016-01-01 – 2016-12-31: -6262000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 10000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2016-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -6272000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6262000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390019004878/ktov-20181231.xml#244144 Filing: 000121390019004878 Input fundies:CapitalExpenditure: 10000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390019004878/ktov-20181231.xml#246841 Filing: 000121390019004878 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	USD 12.18 million Exact value Exact value: 12177000 USD 2017-01-01 – 2017-12-31: 12177000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2017-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 12177000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12177000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml#187239 Filing: 000121390020007156 The citation records this snapshot. The page link may show a newer release later.	−USD 8.63 million Exact value Exact value: -8627000 USD 2017-01-01 – 2017-12-31: -8627000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2017-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -8627000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8627000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml#226008 Filing: 000121390020007156 The citation records this snapshot. The page link may show a newer release later.	USD 13,000 Exact value Exact value: 13000 USD 2017-01-01 – 2017-12-31: 13000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2017-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 13000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml#228687 Filing: 000121390020007156 The citation records this snapshot. The page link may show a newer release later.	−USD 8.64 million Calculation and evidence -8627000 − 13000 USD Exact free cash flow: -8640000 USD 2017-01-01 – 2017-12-31: -8627000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 13000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2017-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -8640000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8627000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml#226008 Filing: 000121390020007156 Input fundies:CapitalExpenditure: 13000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390020007156/ktov-20191231.xml#228687 Filing: 000121390020007156 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 5.2 million Exact value Exact value: 5200000 USD 2018-01-01 – 2018-12-31: 5200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2018-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 5200000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5200000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/ppbt-20201231.xml#597272 Filing: 000121390021015453 The citation records this snapshot. The page link may show a newer release later.	−USD 8.48 million Exact value Exact value: -8480000 USD 2018-01-01 – 2018-12-31: -8480000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2018-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -8480000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8480000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/ppbt-20201231.xml#1092440 Filing: 000121390021015453 The citation records this snapshot. The page link may show a newer release later.	USD 16,000 Exact value Exact value: 16000 USD 2018-01-01 – 2018-12-31: 16000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2018-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 16000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/ppbt-20201231.xml#1094961 Filing: 000121390021015453 The citation records this snapshot. The page link may show a newer release later.	−USD 8.5 million Calculation and evidence -8480000 − 16000 USD Exact free cash flow: -8496000 USD 2018-01-01 – 2018-12-31: -8480000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 16000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2018-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -8496000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8480000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/ppbt-20201231.xml#1092440 Filing: 000121390021015453 Input fundies:CapitalExpenditure: 16000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390021015453/ppbt-20201231.xml#1094961 Filing: 000121390021015453 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 5.85 million Exact value Exact value: 5850000 USD 2019-01-01 – 2019-12-31: 5850000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2019-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 5850000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5850000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1428815 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.	−USD 1.97 million Exact value Exact value: -1968000 USD 2019-01-01 – 2019-12-31: -1968000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2019-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -1968000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1968000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1791261 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.	USD 11,000 Exact value Exact value: 11000 USD 2019-01-01 – 2019-12-31: 11000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2019-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 11000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1770862 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.	−USD 1.98 million Calculation and evidence -1968000 − 11000 USD Exact free cash flow: -1979000 USD 2019-01-01 – 2019-12-31: -1968000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 11000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2019-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -1979000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1968000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1791261 Filing: 000121390022011191 Input fundies:CapitalExpenditure: 11000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1770862 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 28 million Exact value Exact value: 27999000 USD 2020-01-01 – 2020-12-31: 27999000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2020-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 27999000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 27999000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390023017024/f20f2022_purplebiotech.htm#1710177 Filing: 000121390023017024 The citation records this snapshot. The page link may show a newer release later.	USD 1.71 million Exact value Exact value: 1705000 USD 2020-01-01 – 2020-12-31: 1705000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2020-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: 1705000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1705000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1790948 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.	USD 156,000 Exact value Exact value: 156000 USD 2020-01-01 – 2020-12-31: 156000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2020-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 156000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 156000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390023017024/f20f2022_purplebiotech.htm#2039647 Filing: 000121390023017024 The citation records this snapshot. The page link may show a newer release later.	USD 1.55 million Calculation and evidence 1705000 − 156000 USD Exact free cash flow: 1549000 USD 2020-01-01 – 2020-12-31: 1705000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 156000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2020-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: 1549000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1705000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1790948 Filing: 000121390022011191 Input fundies:CapitalExpenditure: 156000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390023017024/f20f2022_purplebiotech.htm#2039647 Filing: 000121390023017024 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 18.38 million Exact value Exact value: 18384000 USD 2021-01-01 – 2021-12-31: 18384000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2021-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: 18384000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18384000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390024020111/ea0200486-20f_purplebio.htm#1422492 Filing: 000121390024020111 The citation records this snapshot. The page link may show a newer release later.	−USD 374,000 Exact value Exact value: -374000 USD 2021-01-01 – 2021-12-31: -374000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2021-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -374000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -374000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1790615 Filing: 000121390022011191 The citation records this snapshot. The page link may show a newer release later.	USD 115,000 Exact value Exact value: 115000 USD 2021-01-01 – 2021-12-31: 115000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2021-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 115000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 115000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390024020111/ea0200486-20f_purplebio.htm#1668120 Filing: 000121390024020111 The citation records this snapshot. The page link may show a newer release later.	−USD 489,000 Calculation and evidence -374000 − 115000 USD Exact free cash flow: -489000 USD 2021-01-01 – 2021-12-31: -374000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 115000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2021-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -489000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -374000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390022011191/f20f2021_purplebiotech.htm#1790615 Filing: 000121390022011191 Input fundies:CapitalExpenditure: 115000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390024020111/ea0200486-20f_purplebio.htm#1668120 Filing: 000121390024020111 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 21.67 million Exact value Exact value: -21668000 USD 2022-01-01 – 2022-12-31: -21668000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2022-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: -21668000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -21668000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm#1496819 Filing: 000121390025022192 The citation records this snapshot. The page link may show a newer release later.	−USD 16.74 million Exact value Exact value: -16735000 USD 2022-01-01 – 2022-12-31: -16735000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2022-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -16735000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -16735000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm#1785461 Filing: 000121390025022192 The citation records this snapshot. The page link may show a newer release later.	USD 26,000 Exact value Exact value: 26000 USD 2022-01-01 – 2022-12-31: 26000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2022-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 26000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 26000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm#1801955 Filing: 000121390025022192 The citation records this snapshot. The page link may show a newer release later.	−USD 16.76 million Calculation and evidence -16735000 − 26000 USD Exact free cash flow: -16761000 USD 2022-01-01 – 2022-12-31: -16735000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 26000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2022-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -16761000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -16735000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm#1785461 Filing: 000121390025022192 Input fundies:CapitalExpenditure: 26000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390025022192/ea0232483-20f_purple.htm#1801955 Filing: 000121390025022192 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 19.88 million Exact value Exact value: -19880000 USD 2023-01-01 – 2023-12-31: -19880000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2023-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: -19880000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19880000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1569587 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	−USD 19.93 million Exact value Exact value: -19925000 USD 2023-01-01 – 2023-12-31: -19925000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2023-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -19925000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19925000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1717588 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2023-01-01 – 2023-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2023-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1724636 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	−USD 19.93 million Calculation and evidence -19925000 − 3000 USD Exact free cash flow: -19928000 USD 2023-01-01 – 2023-12-31: -19925000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2023-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -19928000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19925000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1717588 Filing: 000121390026031365 Input fundies:CapitalExpenditure: 3000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1724636 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 7.24 million Exact value Exact value: -7240000 USD 2024-01-01 – 2024-12-31: -7240000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2024-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: -7240000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7240000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1569205 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	−USD 14.37 million Exact value Exact value: -14367000 USD 2024-01-01 – 2024-12-31: -14367000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2024-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -14367000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14367000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1717187 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 26.39 million Exact value Exact value: -26386000 USD 2025-01-01 – 2025-12-31: -26386000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Net Income: -26386000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26386000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1568818 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	−USD 5.66 million Exact value Exact value: -5656000 USD 2025-01-01 – 2025-12-31: -5656000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Operating Cash Flow: -5656000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1716768 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	USD 3,000 Exact value Exact value: 3000 USD 2025-01-01 – 2025-12-31: 3000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Capital Expenditure: 3000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1723947 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.	−USD 5.66 million Calculation and evidence -5656000 − 3000 USD Exact free cash flow: -5659000 USD 2025-01-01 – 2025-12-31: -5656000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 3000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Kitov Pharma Ltd. · 2025-12-31 Kitov Pharma Ltd. (edgar:1614744) Free cash flow: -5659000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T21:31:18Z Snapshot: 3779788e60cb7e4be169773a23c6497c9d0bfd670a41881be695974586ea89c7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1614744?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5656000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1716768 Filing: 000121390026031365 Input fundies:CapitalExpenditure: 3000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1614744/000121390026031365/ea0281765-20f_purple.htm#1723947 Filing: 000121390026031365 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

382 filings · 578 latest values · 578 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001614744, 1614744, KTOV, PPBT, edgar:1614744

Also known as Kitov Pharma Ltd., Kitov Pharmaceuticals Holdings Ltd., PURPLE BIOTECH LTD., Purple Biotech Ltd.

Kitov Pharma Ltd.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2020 2020-01-01 – 2020-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation